We are live on
!
Find out more
JG
Jain Global Portfolio holdings
AUM
$24.2B
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
-3.54%
1 Year Est. Return
+34.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.39B
AUM Growth
+$5.03B
(+150%)
Cap. Flow
+$5.16B
Cap. Flow
% of AUM
61.57%
Top 10 Holdings %
Top 10 Hldgs %
47.83%
Holding
1,413
New
688
Increased
198
Reduced
147
Closed
371
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$659M |
| 2 |
NVIDIA
NVDA
|
+$222M |
| 3 |
Microsoft
MSFT
|
+$60.3M |
| 4 |
PPG Industries
PPG
|
+$50.3M |
| 5 |
Tesla
TSLA
|
+$48.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$74.1M |
| 2 |
RTX Corp
RTX
|
+$57.5M |
| 3 |
FedEx
FDX
|
+$56.2M |
| 4 |
Broadcom
AVGO
|
+$53.6M |
| 5 |
ConocoPhillips
COP
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.4% |
| 2 | Industrials | 6.13% |
| 3 | Consumer Discretionary | 5.02% |
| 4 | Healthcare | 3.78% |
| 5 | Materials | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Olema Pharmaceuticals
OLMA
$1.01B
| $46.6K | ﹤0.01% |
+12,396
| New | +$62.3K |
|
|
PGRE
1002
DELISTED
Paramount Group
PGRE
| $46.5K | ﹤0.01% |
+10,823
| New | +$48.9K |
|
1003
Arbutus Biopharma
ABUS
$871M
| $46.1K | ﹤0.01% |
+13,200
| New | +$44K |
|
1004
Pliant Therapeutics
PLRX
$66.3M
| $45.9K | ﹤0.01% |
+34,021
| New | +$207K |
|
1005
Mobile Infrastructure Corp
BEEP
$74.6M
| $45.7K | ﹤0.01% |
+10,969
| New | +$42.3K |
|
1006
Erasca
ERAS
$6.3B
| $42.8K | ﹤0.01% |
+31,246
| New | +$53.6K |
|
1007
Veritone
VERI
$96.7M
| $42.2K | ﹤0.01% |
+18,164
| New | +$52.7K |
|
1008
TTEC Holdings
TTEC
$119M
| $42.1K | ﹤0.01% |
+12,788
| New | +$47.2K |
|
1009
Genasys
GNSS
$77M
| $42K | ﹤0.01% |
+18,503
| New | +$51.3K |
|
1010
Tango Therapeutics
TNGX
$4.34B
| $41.5K | ﹤0.01% |
30,303
-19,489
| -39% | -$47.9K |
|
|
IVAC
1011
DELISTED
Intevac Inc
IVAC
| $40.6K | ﹤0.01% |
+10,155
| New | +$38.2K |
|
1012
Opko Health
OPK
$1.25B
| $40.2K | ﹤0.01% |
+24,200
| New | +$39.9K |
|
1013
Immunic
IMUX
$182M
| $39.9K | ﹤0.01% |
+3,662
| New | +$39.5K |
|
1014
C4 Therapeutics
CCCC
$393M
| $38.7K | ﹤0.01% |
+24,203
| New | +$72.2K |
|
1015
Zevia
ZVIA
$116M
| $38.7K | ﹤0.01% |
+17,915
| New | +$58.6K |
|
1016
Fulcrum Therapeutics
FULC
$248M
| $37.6K | ﹤0.01% |
13,051
-2,358
| -15% | -$8.66K |
|
1017
Larimar Therapeutics
LRMR
$398M
| $36K | ﹤0.01% |
16,729
-15,058
| -47% | -$47.6K |
|
1018
Senseonics Holdings Inc
SENS
$256M
| $33.9K | ﹤0.01% |
+2,584
| New | +$42.7K |
|
1019
NovaGold Resources
NG
$2.55B
| $33.8K | ﹤0.01% |
+11,574
| New | +$37.2K |
|
1020
Vivid Seats
SEAT
$88.7M
| $32.4K | ﹤0.01% |
+547
| New | +$44K |
|
1021
Seer Inc
SEER
$118M
| $30.6K | ﹤0.01% |
+18,105
| New | +$39.4K |
|
1022
Nordic American Tanker
NAT
$1.35B
| $30.3K | ﹤0.01% |
+12,300
| New | +$32.4K |
|
1023
SELLAS Life Sciences
SLS
$1.98B
| $29.6K | ﹤0.01% |
+27,400
| New | +$32.5K |
|
|
DHC
1024
Diversified Healthcare Trust
DHC
$2.23B
| $29K | ﹤0.01% |
+12,100
| New | +$29.9K |
|
|
EQC
1025
DELISTED
Equity Commonwealth
EQC
| $26.2K | ﹤0.01% |
16,244
-200,129
| -92% | -$337K |
|
Similar funds
SC
CS
Jain Global's Q1 2025 Portfolio in Review
As of Q1 2025, Jain Global held 1,413 positions worth $8.39B, up 150% from $3.35B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jain Global deployed $5.16B of net new capital in Q1 2025, opening 688 new positions and adding to 198 existing holdings. Its largest new stake was Microsoft: 147,846 shares worth $55.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Arthur J. Gallagher & Co, an estimated $74.1M trimmed.
- Jain Global's largest Q1 2025 buy was Microsoft: 147,846 shares worth $55.5M.
- Jain Global added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $659M increase.
- Jain Global's biggest Q1 2025 reduction was Arthur J. Gallagher & Co, cutting an estimated $74.1M.
- Jain Global fully exited RTX Corp in Q1 2025, selling an estimated $57.5M.
- Jain Global's ten largest holdings make up 48% of its $8.39B portfolio in Q1 2025.
- Jain Global opened 688 new positions and closed 371 in Q1 2025.
- Jain Global's portfolio value rose 150% quarter-over-quarter to $8.39B.
Based on Jain Global's 13F filing for Q1 2025, filed 15 May 2025.